Portal:CPTAC/FeaturedPathways
From WikiPathways
(Difference between revisions)
(updated pathway title) |
(Added RMC pathway) |
||
| Line 14: | Line 14: | ||
|width=100px|{{#pwImage:Pathway:WP3301|250px||MFAP5-mediated ovarian cancer cell motility and invasiveness}} | |width=100px|{{#pwImage:Pathway:WP3301|250px||MFAP5-mediated ovarian cancer cell motility and invasiveness}} | ||
|width=100px|{{#pwImage:Pathway:WP4155|250px||Endometrial cancer}} | |width=100px|{{#pwImage:Pathway:WP4155|250px||Endometrial cancer}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4204|250px||Tumor suppressor activity of SMARCB1}} | ||
|} | |} | ||
Revision as of 21:34, 2 February 2018
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
Image does not exist Bladder Cancer |
Image does not exist EPO Receptor Signaling |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Interferon type I signaling pathways |
Image does not exist Transcriptional activation by NRF2 |
Image does not exist Pathways in clear cell renal cell carcinoma |
|
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist Endometrial cancer |
Image does not exist Tumor suppressor activity of SMARCB1 |
